 
 
EXPLANATION:  CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW . 
        [Brackets ] indicate matter deleted from existing law.  
         Underlining  indicates amendments to bill.  
         Strike out  indicates matter stricken from the bill by amendment or deleted from the law by 
amendment.  
         Italics indicate opposite chamber/conference committee amendments.             *sb0776*      
SENATE BILL 776  
J5, J3    (5lr3286 ) 
ENROLLED BILL  
— Finance/Health and Government Operations  — 
Introduced by Senator Beidle  
 
Read and Examined by Proofreaders:  
 
_______________________________________________  
Proofreader.  
_______________________________________________  
Proofreader.  
 
Sealed with the Great Seal and presented to the Governor, for his approval this  
  
_______ day of _______________ at _________________ _______ o’clock, ________M.  
  
______________________________________________  
President .  
 
CHAPTER ______  
 
AN ACT concerning  1 
 
Workgroup to Study the Rise in Adverse Decisions in the State Health Care 2 
System – Establishment  3 
 
FOR the purpose of establishing the Workgroup to Study the Rise in Adverse Decisions in 4 
the State Health Care System; and generally relating to the Workgroup to Study the 5 
Rise in Adverse Decisions in the State Health Care System.  6 
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 7 
That:  8 
 
 (a) There is a Workgroup to Study the Rise in Adverse Decisions in the State 9 
Health Care System.  10 
 
 (b) The Workgroup consists of the following members:  11 
 
2 SENATE BILL 776   
 
   (1) one member of the Senate of Maryland, appointed by the President of  1 
the Senate;  2 
 
  (2) one member of the House of Delegates, appointed by the Speaker of the 3 
House;  4 
 
  (3) the Maryland Insurance Commissioner, or the Commissioner’s 5 
designee;  6 
 
  (4) the Secretary of Health, or the Secretary’s designee;  7 
 
  (5) (4) the Deputy Secretary of the Maryland Medicaid Program, or the Deputy 8 
Secretary’s designee;  9 
 
  (6) (5) the Executive Director of the Health Services Cost Review Commission, 10 
or the Executive Director’s designee;  11 
 
  (7) (6) the Executive Director of the Maryland Health Care Commission, or the 12 
Executive Director’s designee;  13 
 
  (8) (7) the Executive Director of the Chesapeake Regional Information System 14 
for our Patients, or the Executive Director’s designee; and 15 
 
  (8) the Director of the Health Education and Advocacy Uni t of the Office of 16 
the Attorney General, or the Director’s designee; and   17 
 
  (9) the following members, appointed by the President of the Senate and 18 
Speaker of the House  Governor : 19 
 
   (i) one representative of the Maryland Hospital Association;  20 
 
   (ii) one representative of the League of Life and Health Insurers;  21 
 
   (iii) one representative of a managed care plan;  22 
 
   (iv) two representatives of Maryland hospitals , with one 23 
representative from a large hospital system and one representative from a communi ty 24 
hospital ;  25 
 
   (v) one pharmacy services provider;  26 
 
   (vi) one behavioral health provider;  27 
 
   (vii) one representative of a commercial carrier; and 28 
 
   (viii)  one representative of a patient advocacy organization ; 29 
 
 SENATE BILL 776  3 
 
    (ix) one physician  two physicians ; 1 
 
   (x) one representative of MedChi; and  2 
 
   (xi) one representative of a federally qualified health center . 3 
 
 (c) The Workgroup members shall elect the chair of the Workgroup.  4 
 
 (d) The Health Services Cost Review Commission and the Maryland Insurance 5 
Administration , jointly and in consultation with the Maryland Hospital Association,  shall 6 
provide staff for the Workgroup.  7 
 
 (e) A member of the Workgroup:  8 
 
  (1) may not receive compensation as a member of the Workgroup; but  9 
 
  (2) is entitled t o reimbursement for expenses under the Standard State 10 
Travel Regulations, as provided in the State budget.  11 
 
 (f) The Workgroup shall:  12 
 
  (1) review existing State adverse decision reporting requirements for all 13 
health payers in the State and include in its  final report:  14 
 
   (i) the number of adverse decisions compared to the total number of 15 
claims processed each year on average;  16 
 
   (ii) the number of enrollees in each health plan offered in the State;  17 
 
   (iii) the diagnostic and procedure information for each adverse 18 
decision;  19 
 
   (iv) network adequacy, including provider ratios and geographic 20 
accessibility; and  21 
 
   (v) any other data used to inform the Workgroup’s goal of reducing 22 
adverse decisions;  23 
 
  (2) make recommendations to improve State reporting on adverse 24 
decisions, including recommendations regarding:  25 
 
   (i) standardized definitions of:  26 
 
    1. medical service categories;  27 
 
    2. health settings;  28 
 
4 SENATE BILL 776   
 
     3. adverse decisions; and  1 
 
    4. medical necessity;  2 
 
   (ii) a standardized method for catego rizing adverse decisions and 3 
prior authorization denials;  4 
 
   (iii) a standardized process for reporting grievances or filing 5 
complaints and appealing adverse decisions; and  6 
 
   (iv) a standardized method for reporting clinical outcomes, including 7 
National  Committee for Quality Assurance ratings and Centers for Medicare and Medicaid 8 
Services star ratings;  9 
 
  (3) develop strategies for, and make recommendations to reduce, the 10 
number of adverse decisions; and  11 
 
  (4) develop recommendations for legislation to address the rise in adverse 12 
decisions and standardize State reporting requirements regarding adverse decisions across 13 
all payers.  14 
 
 (g) On or before December 1, 2025, the Workgroup shall report its findings and 15 
recommendations to the Senate Finance Committee and the House Health and 16 
Government Operations Committee, in accordance with § 2 –1257 of the State Government 17 
Article.  18 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect June 19 
1, 2025. It shall remain effective for a period of  1 year and 1 month and, at the end of June 20 
30, 2026, this Act, with no further action required by the General Assembly, shall be 21 
abrogated and of no further force and effect.  22 
 
 
 
Approved:  
________________________________ ________________________________ ________________   
           Governor.  
________________________________ ________________________________ ________________   
                 President of the Senate.  
________________________________ ________________________________ ________________   
         Speaker of the House of Delegates.  